{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T02:50:25Z","timestamp":1788922225437,"version":"build-2803163510"},"reference-count":72,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T00:00:00Z","timestamp":1785196800000},"content-version":"am","delay-in-days":269,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100006108","name":"National Center for Advancing Translational Sciences","doi-asserted-by":"publisher","award":["UL1TR001998"],"award-info":[{"award-number":["UL1TR001998"]}],"id":[{"id":"10.13039\/100006108","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000057","name":"National Institute of General Medical Sciences","doi-asserted-by":"publisher","award":["S10 OD28690"],"award-info":[{"award-number":["S10 OD28690"]}],"id":[{"id":"10.13039\/100000057","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000057","name":"National Institute of General Medical Sciences","doi-asserted-by":"publisher","award":["P20 GM130456"],"award-info":[{"award-number":["P20 GM130456"]}],"id":[{"id":"10.13039\/100000057","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["U01 DA051377"],"award-info":[{"award-number":["U01 DA051377"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1016\/j.ejmech.2025.117991","type":"journal-article","created":{"date-parts":[[2025,7,23]],"date-time":"2025-07-23T06:47:03Z","timestamp":1753253223000},"page":"117991","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["N-(3-Hydroxyphenyl)-3,8-diazabicyclooctanes as opioid receptors probes. 1. Investigation of the phenolic hydroxyl group"],"prefix":"10.1016","volume":"298","author":[{"given":"Riya R.","family":"Trivedi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dan","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marissa C.","family":"Hessing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emily","family":"Prantzalos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Warren J.","family":"Alilain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jill R.","family":"Turner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0649-8052","authenticated-orcid":false,"given":"Thomas E.","family":"Prisinzano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejmech.2025.117991_bib1","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1111\/j.1399-6576.1982.tb01765.x","article-title":"Potent, new analgesics, tailor-made for different purposes","volume":"26","author":"Janssen","year":"1982","journal-title":"Acta Anaesthesiol. Scand."},{"key":"10.1016\/j.ejmech.2025.117991_bib2","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1007\/BF02161116","article-title":"Synthese basisch substituierter, analgetisch wirksamer benzimidazol-derivate","volume":"13","author":"Hunger","year":"1957","journal-title":"Experientia"},{"key":"10.1016\/j.ejmech.2025.117991_bib3","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1007\/BF02161117","article-title":"\u00dcber Benzimidazolderivate mit starker analgetischer Wirkung","volume":"13","author":"Gross","year":"1957","journal-title":"Experientia"},{"key":"10.1016\/j.ejmech.2025.117991_bib4","first-page":"800","article-title":"Benzimidazol-Derivate und verwandte Heterocyclen. II. Synthese von 1-Aminoalkyl-2-benzyl-benzimidazolen, Hel. Chim","volume":"43","author":"Hunger","year":"1960","journal-title":"Acta"},{"key":"10.1016\/j.ejmech.2025.117991_bib5","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1002\/hlca.19610440513","article-title":"Benzimidazol-Derivate und verwandte Heterocyclen VII. Synthese neuer 2-Amino-benzimidazole","volume":"44","author":"Hunger","year":"1961","journal-title":"Helv. Chim. Acta"},{"key":"10.1016\/j.ejmech.2025.117991_bib6","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1021\/acschemneuro.1c00037","article-title":"DARK classics in chemical neuroscience: Etonitazene and related benzimidazole","volume":"12","author":"Ujv\u00e1ry","year":"2021","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.ejmech.2025.117991_bib7","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s11419-018-0454-5","article-title":"The search for the \"next\" euphoric non-fentanil novel synthetic opioids on the illicit drugs market: current status and horizon scanning","volume":"37","author":"Sharma","year":"2019","journal-title":"Forensic Toxicol."},{"key":"10.1016\/j.ejmech.2025.117991_bib8","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1021\/jm00136a010","article-title":"4-Amino-4-Arylcyclohexanones and their derivatives: a novel class of analgesics. 2. Modification of the carbonyl function","volume":"24","author":"Lednicer","year":"1981","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.117991_bib9","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1021\/jm00196a001","article-title":"4-(p-Bromophenyl)-4-(Dimethylamino)-1-Phenethylcyclohexanol, an extremely potent representative of a new analgesic series","volume":"22","author":"Lednicer","year":"1979","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.117991_bib10","series-title":"Drug Overdose Deaths in the United States, 2003\u20132023. NCHS Data Brief, No 522","author":"Garnett","year":"2024"},{"key":"10.1016\/j.ejmech.2025.117991_bib11","series-title":"NCHS Data Brief, No 394","article-title":"Drug overdose deaths in the United States, 1999\u20132019","author":"Hedegaard","year":"2020"},{"key":"10.1016\/j.ejmech.2025.117991_bib12","doi-asserted-by":"crossref","first-page":"9173","DOI":"10.1021\/acs.jmedchem.4c00333","article-title":"Searching for synthetic opioid rescue agents: identification of a potent opioid agonist with reduced respiratory depression","volume":"67","author":"Vu","year":"2024","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.117991_bib13","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1021\/jm00189a007","article-title":"Deoxymorphines: role of the phenolic hydroxyl in antinociception and opiate receptor interactions","volume":"22","author":"Reden","year":"1979","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.117991_bib14","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1038\/nature10954","article-title":"Crystal structure of the \u03bc-Opioid receptor bound to a morphinan antagonist","volume":"485","author":"Manglik","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.ejmech.2025.117991_bib15","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1038\/nature14680","article-title":"Propagation of conformational changes during \u03bc-Opioid receptor activation","volume":"524","author":"Sounier","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.ejmech.2025.117991_bib16","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1038\/nature14886","article-title":"Structural insights into mu-Opioid receptor activation","volume":"524","author":"Huang","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.ejmech.2025.117991_bib17","series-title":"Opioid Analgesics: Chemistry and Receptors","first-page":"333","article-title":"Enkaphalins, endorphins, and other opioid peptides","author":"Casy","year":"1986"},{"key":"10.1016\/j.ejmech.2025.117991_bib18","doi-asserted-by":"crossref","first-page":"2165","DOI":"10.1016\/0024-3205(91)90150-A","article-title":"Mu receptor binding of some commonly used opioids and their metabolites","volume":"48","author":"Chen","year":"1973","journal-title":"Life Sci."},{"key":"10.1016\/j.ejmech.2025.117991_bib19","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1016\/j.jpain.2014.08.010","article-title":"The fentanyl story","volume":"15","author":"Stanley","year":"2014","journal-title":"J. Pain"},{"key":"10.1016\/j.ejmech.2025.117991_bib20","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1021\/jm00139a003","article-title":"Opiate receptor interaction of compounds derived from or structurally related to fentanyl","volume":"24","author":"Lobbezoo","year":"1981","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.117991_bib21","first-page":"879","article-title":"Clinical pharmacology of methadone for pain, acta anaesthesiol","volume":"52","author":"Fredheim","year":"2008","journal-title":"Scand."},{"key":"10.1016\/j.ejmech.2025.117991_bib22","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1001\/archinte.1966.00290160004002","article-title":"Narcotic blockade","volume":"118","author":"Dole","year":"1966","journal-title":"Arch. Intern. Med."},{"key":"10.1016\/j.ejmech.2025.117991_bib23","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1016\/j.ejmech.2018.02.046","article-title":"Benzomorphan scaffold for opioid analgesics and pharmacological tools development: a comprehensive review","volume":"148","author":"Turnaturi","year":"2018","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.117991_bib24","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1007\/BF02532378","article-title":"Cyclazocine revisited","volume":"21","author":"Archer","year":"1996","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.ejmech.2025.117991_bib25","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/S0960-894X(99)00670-8","article-title":"8-Aminocyclazocine analogues: synthesis and structure-activity relationships","volume":"10","author":"Wentland","year":"2000","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2025.117991_bib26","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1016\/S0960-894X(01)00014-2","article-title":"8-Carboxamidocyclazocine analogues: redefining the structure\u2013activity relationships of 2,6-Methano-3-Benzazocines","volume":"11","author":"Wentland","year":"2001","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2025.117991_bib27","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.bmcl.2008.10.134","article-title":"Syntheses and opioid receptor binding properties of carboxamido-substituted opioids","volume":"19","author":"Wentland","year":"2009","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2025.117991_bib28","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1021\/ml100126b","article-title":"1-Substituted 4-(3-Hydroxyphenyl)Piperazines are pure opioid receptor antagonists","volume":"1","author":"Carroll","year":"2010","journal-title":"ACS Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2025.117991_bib29","series-title":"Arylpiperazine Opioid Receptor Antagonists","author":"Carroll","year":"2011"},{"key":"10.1016\/j.ejmech.2025.117991_bib30","doi-asserted-by":"crossref","first-page":"4551","DOI":"10.1021\/jm400275h","article-title":"Discovery of N-{4-[(3-Hydroxyphenyl)-3-Methylpiperazin-1-Yl]Methyl-2-Methylpropyl}-4-Phenoxybenzamide Analogues as Selective Kappa Opioid Receptor Antagonists","volume":"56","author":"Kormos","year":"2013","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.117991_bib31","doi-asserted-by":"crossref","first-page":"3140","DOI":"10.1021\/jm500184j","article-title":"Effect of the 3- and 4-Methyl groups on the opioid receptor properties of N-Substituted Trans-3,4-Dimethyl-4-(3-Hydroxyphenyl)Piperidines","volume":"57","author":"Kormos","year":"2014","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.117991_bib32","doi-asserted-by":"crossref","first-page":"6476","DOI":"10.1021\/jacs.4c00871","article-title":"Transition-metal-free C\u2013N cross-coupling enabled by a multifunctional reagent","volume":"146","author":"Fier","year":"2024","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.ejmech.2025.117991_bib33","doi-asserted-by":"crossref","first-page":"11027","DOI":"10.1021\/acs.jmedchem.6b01235","article-title":"Synthetic studies of neoclerodane diterpenes from salvia divinorum: identification of a potent and centrally acting \u03bc opioid analgesic with reduced abuse liability","volume":"59","author":"Crowley","year":"2016","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.117991_bib34","doi-asserted-by":"crossref","first-page":"10464","DOI":"10.1021\/jm501521d","article-title":"Synthesis and \u03ba-Opioid receptor activity of furan-substituted salvinorin A analogues","volume":"57","author":"Riley","year":"2014","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.117991_bib35","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1002\/cmdc.201700103","article-title":"Synthesis and opioid activity of Tyr1\u2010\u03c8[(Z)CF=CH]\u2010Gly2 and Tyr1\u2010\u03c8[(S)\/(R)\u2010CF3CH\u2010NH]\u2010Gly2 leu\u2010enkephalin fluorinated peptidomimetics","volume":"12","author":"Karad","year":"2017","journal-title":"ChemMedChem"},{"key":"10.1016\/j.ejmech.2025.117991_bib36","doi-asserted-by":"crossref","first-page":"5190","DOI":"10.1021\/jo020184v","article-title":"Naphthalene diols: a new class of antioxidants intramolecular hydrogen bonding in catechols, naphthalene diols, and their aryloxyl radicals","volume":"67","author":"Foti","year":"2002","journal-title":"J. Org. Chem."},{"key":"10.1016\/j.ejmech.2025.117991_bib37","doi-asserted-by":"crossref","first-page":"7889","DOI":"10.1021\/acs.jmedchem.4c03078","article-title":"Tertiary alcohol: reaping the benefits but minimizing the drawbacks of hydroxy groups in drug discovery","volume":"68","author":"Chiodi","year":"2025","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.117991_bib38","doi-asserted-by":"crossref","first-page":"3227","DOI":"10.1021\/jm9018788","article-title":"Oxetanes in drug discovery: structural and synthetic insights","volume":"53","author":"Wuitschik","year":"2010","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.117991_bib39","doi-asserted-by":"crossref","first-page":"5305","DOI":"10.1021\/acs.jmedchem.2c02015","article-title":"\"Magic Chloro\": profound effects of the chlorine atom in drug discovery","volume":"66","author":"Chiodi","year":"2023","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.117991_bib40","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1080\/14756360701425014","article-title":"The role of fluorine in medicinal chemistry","volume":"22","author":"Shah","year":"2007","journal-title":"J. Enzym. Inhib. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.117991_bib41","doi-asserted-by":"crossref","first-page":"1626","DOI":"10.1021\/jo00111a021","article-title":"Hydrogen bond donor properties of the difluoromethyl group","volume":"60","author":"Erickson","year":"1995","journal-title":"J. Org. Chem."},{"key":"10.1016\/j.ejmech.2025.117991_bib42","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1021\/acs.jmedchem.6b01691","article-title":"Difluoromethyl bioisostere: examining the \"Lipophilic Hydrogen Bond Donor\" concept","volume":"60","author":"Zafrani","year":"2017","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.117991_bib43","doi-asserted-by":"crossref","first-page":"9325","DOI":"10.1021\/jacs.7b04457","article-title":"CF2H, a hydrogen bond donor","volume":"139","author":"Sessler","year":"2017","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.ejmech.2025.117991_bib44","doi-asserted-by":"crossref","first-page":"4270","DOI":"10.1016\/j.ejmech.2010.06.026","article-title":"Extending pKa prediction accuracy: high-throughput pKa measurements to understand pKa modulation of new chemical series","volume":"45","author":"Milletti","year":"2010","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.117991_bib45","doi-asserted-by":"crossref","DOI":"10.1002\/ardp.202400700","article-title":"Phenol (bio)isosteres in drug design and development","volume":"358","author":"Dunker","year":"2025","journal-title":"Arch. Pharm."},{"key":"10.1016\/j.ejmech.2025.117991_bib46","doi-asserted-by":"crossref","first-page":"3262","DOI":"10.1039\/D0CS00102C","article-title":"Peptidomimetic toolbox for drug discovery","volume":"49","author":"Lenci","year":"2020","journal-title":"Chem. Soc. Rev."},{"key":"10.1016\/j.ejmech.2025.117991_bib47","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1021\/acsmedchemlett.7b00002","article-title":"Intramolecular hydrogen bond expectations in medicinal chemistry","volume":"8","author":"Giordanetto","year":"2017","journal-title":"ACS Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2025.117991_bib48","doi-asserted-by":"crossref","first-page":"12290","DOI":"10.1021\/acs.jmedchem.0c00530","article-title":"Amide bond bioisosteres: strategies, synthesis, and successes","volume":"63","author":"Kumari","year":"2020","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.117991_bib49","doi-asserted-by":"crossref","first-page":"13","DOI":"10.3390\/molecules26010013","article-title":"Pharmacological characterization of \u039c-Opioid receptor agonists with biased G protein or \u03b2-Arrestin signaling, and computational study of conformational changes during receptor activation","volume":"26","author":"Piekielna-Ciesielska","year":"2020","journal-title":"Molecules"},{"key":"10.1016\/j.ejmech.2025.117991_bib50","doi-asserted-by":"crossref","first-page":"4361","DOI":"10.1016\/j.cell.2022.09.041","article-title":"Molecular recognition of morphine and fentanyl by the human \u03bc-opioid receptor","volume":"185","author":"Zhuang","year":"2022","journal-title":"Cell"},{"key":"10.1016\/j.ejmech.2025.117991_bib51","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/S0022-3565(25)10296-6","article-title":"Neuroanatomical sites mediating the motivational effects of opioids as mapped by the conditioned place preference paradigm in rats","volume":"264","author":"Bals-Kubik","year":"1993","journal-title":"J. Pharmacol. Exp. Therapeut."},{"key":"10.1016\/j.ejmech.2025.117991_bib52","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1021\/jm00175a013","article-title":"Synthesis and pharmacology of 8-Amino-3-(Cyclopropylmethyl)-1,2,3,4,5,6-Hexahydro-Cis-6,11-Dimethyl-2,6-Methano-3-Benzazocine and related compounds","volume":"23","author":"Wentland","year":"1980","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.117991_bib53","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1124\/jpet.302.1.374","article-title":"8-Carboxamidocyclazocine: a long-acting, novel benzomorphan","volume":"302","author":"Bidlack","year":"2002","journal-title":"J. Pharmacol. Exp. Therapeut."},{"key":"10.1016\/j.ejmech.2025.117991_bib54","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1023\/A:1018943613122","article-title":"Physiological parameters in laboratory animals and humans","volume":"10","author":"Davies","year":"1993","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ejmech.2025.117991_bib55","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/S0091-3057(98)00232-9","article-title":"Pharmacologic and behavioral responses of inbred C57BL\/6J and strain 129\/SvJ mouse lines","volume":"63","author":"Homanics","year":"1999","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.ejmech.2025.117991_bib56","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1016\/j.pbb.2009.01.019","article-title":"Receptor reserve reflects differential intrinsic efficacy associated with opioid diastereomers","volume":"92","author":"Carliss","year":"2009","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.ejmech.2025.117991_bib57","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1042\/BST20120331","article-title":"Ligand bias at the \u03bc-opioid receptor","volume":"41","author":"Kelly","year":"2013","journal-title":"Biochem. Soc. Trans."},{"key":"10.1016\/j.ejmech.2025.117991_bib58","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2021.107961","article-title":"Experimental considerations for the assessment of in vivo and in vitro opioid pharmacology","volume":"230","author":"Hill","year":"2022","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.ejmech.2025.117991_bib59","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1016\/S1471-4892(01)00091-1","article-title":"Reporter-gene systems for the study of G-Protein-Coupled receptors","author":"Hill","year":"2001","journal-title":"Curr. Opin. Pharmacol."},{"key":"10.1016\/j.ejmech.2025.117991_bib60","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1111\/j.1476-5381.1977.tb07533.x","article-title":"The animal pharmacology of buprenorphine, an oripavine analgesic agent","volume":"60","author":"Cowan","year":"1977","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ejmech.2025.117991_bib61","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1111\/j.1476-5381.1977.tb07532.x","article-title":"Agonist and antagonist properties of buprenorphine, a new antinociceptive agent","volume":"60","author":"Cowan","year":"1977","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ejmech.2025.117991_bib62","doi-asserted-by":"crossref","first-page":"1656","DOI":"10.1038\/sj.npp.1300463","article-title":"Buprenorphine antinociception is abolished, but naloxone-sensitive reward is retained, in \u03bc-Opioid receptor knockout mice: preclinical research","volume":"29","author":"Ide","year":"2004","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.ejmech.2025.117991_bib63","doi-asserted-by":"crossref","first-page":"10331","DOI":"10.1523\/JNEUROSCI.23-32-10331.2003","article-title":"Buprenorphine-induced antinociception is mediated by \u03bc-Opioid receptors and compromised by concomitant activation of opioid receptor-like receptors","volume":"23","author":"Lutfy","year":"2003","journal-title":"J. Neurosci."},{"key":"10.1016\/j.ejmech.2025.117991_bib64","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1093\/bja\/aei145","article-title":"Comparison of the respiratory effects of intravenous buprenorphine and fentanyl in humans and rats","volume":"94","author":"Dahan","year":"2005","journal-title":"Br. J. Anaesth."},{"key":"10.1016\/j.ejmech.2025.117991_bib65","first-page":"423","article-title":"Structure-activity relationships of synthetic and semisynthetic opioid agonists and antagonists","volume":"1","author":"Furst","year":"1995","journal-title":"Acta Pharm. Hung."},{"key":"10.1016\/j.ejmech.2025.117991_bib66","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1021\/jm00003a019","article-title":"(+)-Cis-N-(Para-, Meta-, and ortho-substituted Benzyl)-N-Normetazocines: synthesis and binding affinity at the [3H]-(+)-Pentazocine-Labeled (.Sigma.1) site and quantitative structure-affinity relationship studies","volume":"38","author":"Mascarella","year":"1995","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.117991_bib67","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1021\/ol005561+","article-title":"Investigation of phenolic bioisosterism in opiates: 3-sulfonamido analogues of naltrexone and oxymorphone","volume":"2","author":"McCurdy","year":"2000","journal-title":"Org. Lett."},{"key":"10.1016\/j.ejmech.2025.117991_bib68","doi-asserted-by":"crossref","first-page":"3558","DOI":"10.1021\/jm000119i","article-title":"Selective protection and functionalization of morphine: synthesis and opioid receptor binding properties of 3-Amino-3-Desoxymorphine derivatives","volume":"43","author":"Wentland","year":"2000","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.117991_bib69","doi-asserted-by":"crossref","first-page":"1717","DOI":"10.1016\/S0960-894X(01)00278-5","article-title":"3-Carboxamido analogues of morphine and naltrexone: synthesis and opioid receptor binding properties","volume":"11","author":"Wentland","year":"2001","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2025.117991_bib70","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1016\/j.tetlet.2016.02.006","article-title":"Unified syntheses of gramniphenols F and G, cicerfuran, morunigrol C and its derivative","volume":"57","author":"Damodar","year":"2016","journal-title":"Tetrahedron Lett."},{"key":"10.1016\/j.ejmech.2025.117991_bib71","doi-asserted-by":"crossref","first-page":"4795","DOI":"10.3390\/molecules28124795","article-title":"Discovery of a potent highly biased MOR partial agonist among diastereomeric C9-Hydroxyalkyl-5-phenylmorphans","volume":"28","author":"Lutz","year":"2023","journal-title":"Molecules"},{"key":"10.1016\/j.ejmech.2025.117991_bib72","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1016\/S0022-3565(25)09094-9","article-title":"The evaluation of the analgesic actions of pethidine hydrochloride (demerol)","volume":"80","author":"Woolfe","year":"1944","journal-title":"J. Pharmacol. Exp. Therapeut."}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523425007561?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523425007561?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T04:40:01Z","timestamp":1772772001000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0223523425007561"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11]]},"references-count":72,"alternative-id":["S0223523425007561"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2025.117991","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2025,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"N-(3-Hydroxyphenyl)-3,8-diazabicyclooctanes as opioid receptors probes. 1. Investigation of the phenolic hydroxyl group","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2025.117991","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Masson SAS. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"117991"}}